EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Clinical importance of changes in magnetic resonance biomarkers for Duchenne muscular dystrophy

Rebecca J Willcocks iD, Alison M Barnard iD, Michael J Daniels, Sean C Forbes, William T Triplett, John F Brandsema, Erika L Finanger, William D Rooney, Sarah Kim iD, Dah-Jyuu Wang, Donovan J Lott, Claudia R Senesac und 3 weitere

Annals of Clinical and Translational Neurology · 2024-01 · 11 (1) · 67-78

DOI: 10.1002/acn3.51933 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Clinical and Translational Neurology, online erschienen am 06.11.2023. Verfasst von Rebecca J Willcocks und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physical Therapy, College of Public Health and Health Professions, University of Florida, Gainesville, Florida, USA. Hauptthemen laut MEDLINE: Muscular Dystrophy, Duchenne. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIH HHS, NICHD NIH HHS, NIAMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Magnetic resonance (MR) measures of muscle quality are highly sensitive to disease progression and predictive of meaningful functional milestones in Duchenne muscular dystrophy (DMD). This investigation aimed to establish the reproducibility, responsiveness to disease progression, and minimum clinically important difference (MCID) for multiple MR biomarkers at different disease stages in DMD using a large natural history dataset.

Methods

Longitudinal MR imaging and spectroscopy outcomes and ambulatory function were measured in 180 individuals with DMD at three sites, including repeated measurements on two separate days (within 1 week) in 111 participants. These data were used to calculate day‐to‐day reproducibility, responsiveness (standardized response mean, SRM), minimum detectable change, and MCID. A survey of experts was also performed.

Results

MR spectroscopy fat fraction (FF), as well as MR imaging transverse relaxation time (MRI‐T 2 ), measures performed in multiple leg muscles, and had high reproducibility (Pearson's R > 0.95). Responsiveness to disease progression varied by disease stage across muscles. The average FF from upper and lower leg muscles was highly responsive (SRM > 0.9) in both ambulatory and nonambulatory individuals. MCID estimated from the distribution of scores, by anchoring to function, and via expert opinion was between 0.01 and 0.05 for FF and between 0.8 and 3.7 ms for MRI‐T 2 .

Interpretation

MR measures of FF and MRI T 2 are reliable and highly responsive to disease progression. The MCID for MR measures is less than or equal to the typical annualized change. These results confirm the suitability of these measures for use in DMD and potentially other muscular dystrophies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Muscular Dystrophy, DuchenneHumansClinical RelevanceReproducibility of ResultsMagnetic Resonance SpectroscopyMagnetic Resonance ImagingBiomarkersDisease Progression

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Physical Therapy, College of Public Health and Health Professions, University of Florida, Gainesville, Florida, USA.
  • Department of Statistics, University of Florida, Gainesville, Florida, USA.
  • Division of Neurology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Department of Pediatrics and Neurology, Oregon Health & Science University, Portland, Oregon, USA.
  • Advanced Imaging Research Center, Oregon Health & Science University, Portland, Oregon, USA.
  • Department of Pharmaceutics, Center for Pharmacometrics and Systems Pharmacology, College of Pharmacy, University of Florida, Gainesville, Florida, USA.

ORCID-Profile: Rebecca J Willcocks, Alison M Barnard, Sarah Kim

Förderung

  • NIH HHS
  • NICHD NIH HHS
  • NIAMS NIH HHS
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases
  • National Institutes of Health
  • National Science Foundation
  • Florida Department of State

Zitieren

APA

Willcocks, R. J., Barnard, A. M., Daniels, M. J., Forbes, S. C., Triplett, W. T., Brandsema, J. F., Finanger, E. L., Rooney, W. D., Kim, S., Wang, D. J., Lott, D. J., Senesac, C. R., Walter, G. A., Sweeney, H. L., & Vandenborne, K. (2024). Clinical importance of changes in magnetic resonance biomarkers for Duchenne muscular dystrophy. Annals of Clinical and Translational Neurology, 11(1), 67-78. https://doi.org/10.1002/acn3.51933

Vancouver

Willcocks RJ, Barnard AM, Daniels MJ, Forbes SC, Triplett WT, Brandsema JF, et al. Clinical importance of changes in magnetic resonance biomarkers for Duchenne muscular dystrophy. Annals of Clinical and Translational Neurology. 2024;11(1):67-78. doi:10.1002/acn3.51933

BibTeX
@article{Willcocks2024,
  author = {Willcocks, Rebecca J and Barnard, Alison M and Daniels, Michael J and Forbes, Sean C and Triplett, William T and Brandsema, John F and Finanger, Erika L and Rooney, William D and Kim, Sarah and Wang, Dah-Jyuu and Lott, Donovan J and Senesac, Claudia R and Walter, Glenn A and Sweeney, H Lee and Vandenborne, Krista},
  title = {Clinical importance of changes in magnetic resonance biomarkers for Duchenne muscular dystrophy},
  journal = {Annals of Clinical and Translational Neurology},
  year = {2024},
  volume = {11},
  number = {1},
  pages = {67--78},
  doi = {10.1002/acn3.51933}
}
Kostenlos starten →